PANACEA BIOTEC
Back to Income Statement
|
PANACEA BIOTEC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-8.37 Cr | ₹-1.17 Cr | ₹-33 Cr | ₹1,078 Cr | ₹-148 Cr |
What is the latest Consolidated Net Profit of PANACEA BIOTEC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-8.37 Cr |
| Mar2025 | ₹-1.17 Cr |
| Mar2024 | ₹-33 Cr |
| Mar2023 | ₹1,078 Cr |
| Mar2022 | ₹-148 Cr |
How is Consolidated Net Profit of PANACEA BIOTEC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-8.37 Cr | Negative | |
| Mar2025 | ₹-1.17 Cr | Negative | |
| Mar2024 | ₹-33 Cr | Negative | |
| Mar2023 | ₹1,078 Cr | Positive | |
| Mar2022 | ₹-148 Cr | - | |
Compare Consolidated Net Profit of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,282.8 Cr | -0.9% | -6.5% | -12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -0.9% |
-6.5% |
-12.1% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses